Network correlates of disease severity in multiple system atrophy

Neurology

Volumn 78, Issue 16, 2012, Pages 1237-1244

  Poston, K L ^a   Tang, C C ^b   Eckert, T ^b,f   Dhawan, V ^b   Frucht, S ^c   Vonsattel, J P ^d   Fahn, S ^e   Eidelberg, D ^b  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e NEUROLOGICAL INSTITUTE   (United States)

^f OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ARTICLE; BRAIN METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; IDIOPATHIC DISEASE; MALE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MULTIPLE SYSTEM ATROPHY RELATED SPATIAL COVARIANCE PATTERN; PARKINSON DISEASE; PARKINSON DISEASE RELATED SPATIAL COVARIANCE PATTERN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RATING SCALE; SHY DRAGER SYNDROME;

EID: 84860755196     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318250d7fd     Document Type: Article

References (28)

1. Eckert T, Tang C, Ma Y, et al. Abnormal metabolic networks in atypical parkinsonism. Mov Disord 2008;23: 727-733.
2. Spetsieris PG, Ma Y, Dhawan V, Eidelberg D. Differential diagnosis of parkinsonian syndromes using PCA-based functional imaging features. Neuroimage 2009;45:1241-1252.
3. Tang CC, Poston KL, Eckert T, et al. Differential diagnosis of parkinsonism: A metabolic imaging study using pattern analysis. Lancet Neurol 2010;9:149-158.
4. Eidelberg D. Metabolic brain networks in neurodegenerative disorders: A functional imaging approach. Trends Neurosci 2009;32:548-557.
5. Litvan I, Bhatia KP, Burn DJ, et al. SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders. Mov Disord 2003;18:467-486. (Pubitemid 36656531)
6. Geser F, Wenning GK, Seppi K, et al. Progression of multiple system atrophy (MSA): A prospective natural history study by the European MSA Study Group (EMSA SG). Mov Disord 2006;21:179-186.
7. Papp MI, Lantos PL. The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomatology. Brain 1994;117:235-243. (Pubitemid 24155496)
8. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
9. Asanuma K, Tang C, Ma Y, et al. Network modulation in the treatment of Parkinson's disease. Brain 2006;129: 2667-2678. (Pubitemid 44522100)
10. Ma Y, Tang C, Spetsieris PG, et al. Abnormal metabolic network activity in Parkinson's disease: Test-retest reproducibility. J Cereb Blood Flow Metab 2007;27:597-605.
11. Spetsieris PG, Eidelberg D. Scaled subprofile modeling of resting state imaging data in Parkinson's disease: Methodological issues. Neuroimage 2011;54:2899-2914.
12. Moeller JR, Nakamura T, Mentis MJ, et al. Reproducibility of regional metabolic covariance patterns: Comparison of four populations. J Nucl Med 1999;40: 1264-1269. (Pubitemid 29385633)
13. Eidelberg D, Takikawa S, Moeller JR, et al. Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson's disease. Ann Neurol 1993;33:518-527. (Pubitemid 23143037)
14. Antonini A, Kazumata K, Feigin A, et al. Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PET. Mov Disord 1998;13:268-274.
15. Eckert T, Barnes A, Dhawan V, et al. FDG PET in the differential diagnosis of parkinsonian disorders. Neuroimage 2005;26:912-921. (Pubitemid 40825033)
16. Tison F, Yekhlef F, Chrysostome V, et al. Parkinsonism in multiple system atrophy: Natural history, severity (UPDRS-III), and disability assessment compared with Parkinson's disease. Mov Disord 2002;17:701-709. (Pubitemid 41295009)
17. Seppi K, Yekhlef F, Diem A, et al. Progression of parkinsonism in multiple system atrophy. J Neurol 2005;252: 91-96. (Pubitemid 40179024)
18. O'Sullivan SS, Massey LA, Williams DR, et al. Clinical outcomes of progressive supranuclear palsy and multiple system atrophy. Brain 2008;131:1362-1372.
19. Bensimon G, Ludolph A, Agid Y, et al. Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: The NNIPPS Study. Brain 2009;132:156-171.
20. Dodel R, Spottke A, Gerhard A, et al. Minocycline 1-year therapy in multiple-system-atrophy: Effect on clinical symptoms and [11C] (R)-PK11195 PET (MEMSA-trial). Mov Disord 2010;25:97-107.
21. May S, Gilman S, Sowell BB, et al. Potential outcome measures and trial design issues for multiple system atrophy. Mov Disord 2007;22:2371-2377 (Pubitemid 351155983)
22. Litvan I, Goetz CG, Jankovic J, et al. What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study. Arch Neurol 1997;54:937-944. (Pubitemid 27330401)
23. Osaki Y, Wenning GK, Daniel SE, et al. Do published criteria improve clinical diagnostic accuracy in multiple system atrophy? Neurology 2002;59:1486-1491. (Pubitemid 35387051)
24. Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 2002;125: 861-870. (Pubitemid 34279780)
25. Lyoo CH, Jeong Y, Ryu YH, et al. Effects of disease duration on the clinical features and brain glucose metabolism in patients with mixed type multiple system atrophy. Brain 2008;131:438-446. (Pubitemid 351197623)
26. Ozawa T, Paviour D, Quinn NP, et al. The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: Clinicopathological correlations. Brain 2004;127:2657-2671. (Pubitemid 39627375)
27. Maldjian JA, Laurienti PJ, Kraft RA, Burdette JH. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage 2003;19:1233-1239. (Pubitemid 36918259)
28. Huang C, Tang C, Feigin A, et al. Changes in network activity with the progression of Parkinson's disease. Brain 2007;130:1834-1846. (Pubitemid 47343798)